ATOPICA® (cyclosporine capsules) USP MODIFIED

A proven product for atopic dermatitis for dogs.

Atopica targets the cause of the problem to help reduce the incessant scratching, rubbing and licking.

Atopic Dermatitis:

• Is a lifelong condition.¹
• Can be seasonal or year-round.¹
• Is one of the most common causes of itching in dogs.²

ATOPICA:

• Is the first medication specifically approved for the control of chronic atopic dermatitis in dogs weighing at least 4 lbs. (1.8 kg).
• Effectively relieves itchiness and reduces skin lesions.
• Provides proven long-term relief.
• 98% of pet owners would recommend to friends.³

If your dog is constantly scratching or licking, it may be suffering from atopic dermatitis. To help your veterinarian evaluate your dog, click here to take a 1-minute canine atopic dermatitis quiz. Print the results and bring them to your appointment.

If you're a veterinarian, click here to learn more

Indications

ATOPICA is indicated for the control of atopic dermatitis in dogs weighing at least 4 pounds.

Important Safety Information

Do not use Atopica in dogs with a history of neoplasia, with a hypersensitivity to cyclosporine, or in reproducing dogs. Atopica is a systemic immunosuppressant that may increase susceptibility to infection and development of neoplasia. For use only in dogs. Capsules should not be broken or opened. Wear gloves during administration and wash hands after administration. Gastrointestinal problems and gingival hyperplasia may occur at the initial dose. Safety and effectiveness has not been established in dogs less than 6 months or 4 lbs. Use with caution in dogs with diabetes mellitus or renal insufficiency, and with drugs that affect the P-450 pathway. Killed vaccines are recommended. The most common adverse events are vomiting and diarrhea. Please see product insert for full prescribing information.

1. Scott DW, Miller WH, Griffin CE. 2001. Skin immune system and allergic skin disease. In: Muller and Kirk's Small Animal Dermatology. 6th ed. 543-666.
2. Hillier A, Griffin CE. 2001. The ACVD task force on canine atopic dermatitis (I): incidence and prevalence. Vet Immunology Immunopathology. 81:147-151.
3. Elanco Animal Health. Data on File.

Atopica is a trademark of Eli Lilly and Company or its affiliates.